Stopping oral antiviral treatment to cure chronic hepatitis B, is it in sight?

Saved in:
Bibliographic Details
Published inHepatology international Vol. 14; no. 3; pp. 302 - 304
Main Authors Fan, Rong, Hou, Jinlin
Format Journal Article
LanguageEnglish
Published New Delhi Springer India 01.05.2020
Springer Nature B.V
Subjects
Antiviral Agents - pharmacology
Antiviral drugs
Colorectal Surgery
Duration of Therapy
Editorial
Hepatitis
Hepatitis B
Hepatitis B Surface Antigens - blood
Hepatitis B virus - immunology
Hepatitis B, Chronic - drug therapy
Hepatitis B, Chronic - immunology
Hepatology
Humans
Immunity
Medicine
Medicine & Public Health
Nucleosides - pharmacology
Risk Adjustment - methods
Risk Assessment
Surgery
Withholding Treatment - ethics
Withholding Treatment - standards
Withholding Treatment - trends
Online AccessGet full text

Cover

Author Fan, Rong
Hou, Jinlin
Author_xml – sequence: 1
  givenname: Rong
  surname: Fan
  fullname: Fan, Rong
  organization: Department of Infectious Diseases, Nanfang Hospital, Southern Medical University
– sequence: 2
  givenname: Jinlin
  surname: Hou
  fullname: Hou, Jinlin
  email: jlhousmu@163.com
  organization: Department of Infectious Diseases, Nanfang Hospital, Southern Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32304087$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1P3DAQhq0KVFjaP9BDZamXHgiMv5L4VAHiS1rRQ9uzZZLZXaOsndoOUv89XnahEgcu47H0vDOv5p2RPR88EvKFwQkDaE4T49DwCjhU5S90pT-QQ6ZFXYGSbO-1F-KAzFJ6AFCqZvVHciC4AAltc0jufuUwjs4vaYh2oNZn9-g2XY5o8xp9pjnQbopIu1UM3nV0haPNLrtEz49pqS5T52lyy1X-8YnsL-yQ8PPuPSJ_ri5_X9xU85_Xtxdn86oTUueqYWhlXwNrLRaTHFulkUtZXNmGqbYFqVWLvbpfMIXAhVJM9q3srVK96rk4It-3c8cY_k6Yslm71OEwWI9hSoYLzXRTq1oX9Nsb9CFM0Rd3hkvgClRTN4X6uqOm-zX2ZoxubeM_83KpAvAt0MWQUsTFK8LAbOIw2zhMicM8x2E2u9s3os7lcrzgc7RueF8qttJU9vglxv-231E9AUtsm1U
CitedBy_id crossref_primary_10_1111_jgh_16791
Cites_doi 10.1007/s12072-019-09991-y
10.1016/j.jhep.2017.07.012
10.1016/S2468-1253(19)30015-9
10.1111/apt.15058
10.1002/hep.28438
10.1093/infdis/jiaa136
10.1007/s12072-014-9593-x
10.1136/gutjnl-2019-318981
10.1002/hep.29640
10.1111/hepr.12269
ContentType Journal Article
Copyright Asian Pacific Association for the Study of the Liver 2020
Asian Pacific Association for the Study of the Liver 2020.
Copyright_xml – notice: Asian Pacific Association for the Study of the Liver 2020
– notice: Asian Pacific Association for the Study of the Liver 2020.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7U7
C1K
K9.
NAPCQ
7X8
DOI 10.1007/s12072-020-10039-9
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Toxicology Abstracts
Environmental Sciences and Pollution Management
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Toxicology Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1936-0541
EndPage 304
ExternalDocumentID 32304087
10_1007_s12072_020_10039_9
Genre Editorial
Commentary
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 81700530; 81772187
  funderid: http://dx.doi.org/10.13039/501100001809
– fundername: National Major Science and Technology Projects of China
  grantid: 2018ZX10301202
  funderid: http://dx.doi.org/10.13039/501100013076
– fundername: National Natural Science Foundation of China
  grantid: 81700530
– fundername: National Major Science and Technology Projects of China
  grantid: 2018ZX10301202
– fundername: National Natural Science Foundation of China
  grantid: 81772187
GroupedDBID ---
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
203
29I
29~
2J2
2JN
2KG
2KM
2LR
2VQ
2~H
30V
3V.
4.4
406
408
40D
53G
5GY
5VS
67Z
6NX
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACCUX
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
AOIJS
ARMRJ
AXYYD
B-.
BAWUL
BDATZ
BENPR
BGNMA
BKEYQ
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DIK
DNIVK
DPUIP
DU5
E3Z
EBLON
EBS
EIOEI
EJD
EN4
ESBYG
EX3
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GX1
H13
HF~
HG6
HMCUK
HMJXF
HRMNR
HYE
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXD
IZQ
J-C
J0Z
JBSCW
JZLTJ
KOV
LLZTM
M1P
M4Y
MA-
NAPCQ
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OK1
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
QOR
QOS
R89
R9I
ROL
RPM
RPX
RSV
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZ9
SZN
T13
TR2
TSG
TSK
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK8
WOW
YLTOR
Z45
Z7U
Z87
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7U7
ABRTQ
C1K
K9.
7X8
ID FETCH-LOGICAL-c349t-71ea4d6018ae1932e859e244304a7158804958ed5bf15e0235514d84da55d5d23
IEDL.DBID U2A
ISSN 1936-0533
1936-0541
IngestDate Fri Jul 11 02:41:47 EDT 2025
Fri Jul 25 22:47:37 EDT 2025
Thu Apr 03 06:59:13 EDT 2025
Tue Jul 01 00:55:07 EDT 2025
Thu Apr 24 23:08:01 EDT 2025
Fri Feb 21 02:34:42 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c349t-71ea4d6018ae1932e859e244304a7158804958ed5bf15e0235514d84da55d5d23
Notes SourceType-Scholarly Journals-1
content type line 14
ObjectType-Editorial-2
ObjectType-Commentary-1
content type line 23
OpenAccessLink https://link.springer.com/content/pdf/10.1007/s12072-020-10039-9.pdf
PMID 32304087
PQID 2402505767
PQPubID 1486344
PageCount 3
ParticipantIDs proquest_miscellaneous_2391976569
proquest_journals_2402505767
pubmed_primary_32304087
crossref_primary_10_1007_s12072_020_10039_9
crossref_citationtrail_10_1007_s12072_020_10039_9
springer_journals_10_1007_s12072_020_10039_9
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-05-01
PublicationDateYYYYMMDD 2020-05-01
PublicationDate_xml – month: 05
  year: 2020
  text: 2020-05-01
  day: 01
PublicationDecade 2020
PublicationPlace New Delhi
PublicationPlace_xml – name: New Delhi
– name: United States
– name: Tokyo
PublicationTitle Hepatology international
PublicationTitleAbbrev Hepatol Int
PublicationTitleAlternate Hepatol Int
PublicationYear 2020
Publisher Springer India
Springer Nature B.V
Publisher_xml – name: Springer India
– name: Springer Nature B.V
References Fan, Peng, Xie (CR13) 2020
Hadziyannis, Sevastianos, Rapti (CR2) 2012; 143
Jeng, Chen, Chien (CR4) 2018; 68
Chen, Hu, Wang (CR7) 2019
CR14
Lim, Amarapurkar, Chan (CR8) 2015; 9
Hou, Zhao, Lee (CR1) 2020; 18
CR10
Hsu, Nguyen, Mo (CR11) 2019; 49
Buti, Wong, Gane (CR6) 2019; 4
Papatheodoridis, Vlachogiannakos, Cholongitas (CR9) 2016; 63
Berg, Simon, Mauss (CR3) 2017; 67
Liem, Fung, Wong (CR5) 2019; 68
Fan, Zhou, Xu (CR12) 2020; 18
10039_CR14
KS Liem (10039_CR5) 2019; 68
R Fan (10039_CR13) 2020
10039_CR10
SG Lim (10039_CR8) 2015; 9
M Buti (10039_CR6) 2019; 4
T Berg (10039_CR3) 2017; 67
W-J Jeng (10039_CR4) 2018; 68
SJ Hadziyannis (10039_CR2) 2012; 143
C-H Chen (10039_CR7) 2019
YC Hsu (10039_CR11) 2019; 49
R Fan (10039_CR12) 2020; 18
G Papatheodoridis (10039_CR9) 2016; 63
JL Hou (10039_CR1) 2020; 18
References_xml – year: 2019
  ident: CR7
  article-title: Comparison of HBsAg changes between HBeAg-negative patients who discontinued or maintained entecavir therapy
  publication-title: Hepatol Int
  doi: 10.1007/s12072-019-09991-y
– volume: 67
  start-page: 918
  year: 2017
  end-page: 924
  ident: CR3
  article-title: Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients—FINITE study
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2017.07.012
– volume: 4
  start-page: 296
  year: 2019
  end-page: 304
  ident: CR6
  article-title: Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials
  publication-title: Lancet Gastroenterol Hepatol
  doi: 10.1016/S2468-1253(19)30015-9
– volume: 49
  start-page: 107
  year: 2019
  end-page: 115
  ident: CR11
  article-title: Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/apt.15058
– volume: 63
  start-page: 1481
  year: 2016
  end-page: 1492
  ident: CR9
  article-title: Discontinuation of oral antivirals in chronic hepatitis B: a systematic review
  publication-title: Hepatology
  doi: 10.1002/hep.28438
– year: 2020
  ident: CR13
  article-title: Combining HBV RNA and hepatitis B core-related antigen: guidance for safely stopping nucleos(t)ide analogues in HBeAg-positive chronic hepatitis B patients
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiaa136
– ident: CR14
– volume: 9
  start-page: 43
  year: 2015
  end-page: 51
  ident: CR8
  article-title: Reimbursement policies in the Asia-Pacific for chronic hepatitis B
  publication-title: Hepatol Int
  doi: 10.1007/s12072-014-9593-x
– ident: CR10
– volume: 68
  start-page: 2206
  year: 2019
  end-page: 2213
  ident: CR5
  article-title: Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study)
  publication-title: Gut
  doi: 10.1136/gutjnl-2019-318981
– volume: 68
  start-page: 425
  year: 2018
  end-page: 434
  ident: CR4
  article-title: Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen–negative chronic hepatitis B
  publication-title: Hepatology
  doi: 10.1002/hep.29640
– volume: 18
  start-page: e421
  issue: 457–467
  year: 2020
  ident: CR1
  article-title: Outcomes of long-term treatment of chronic HBV infection with entecavir or other agents from a randomized trial in 24 countries
  publication-title: Clin Gastroenterol Hepatol
– volume: 18
  start-page: e717
  issue: 719–727
  year: 2020
  ident: CR12
  article-title: Association between negative results from tests for HBV DNA and RNA and durability of response after discontinuation of nucles(t)ide analogue therapy
  publication-title: Clin Gastroenterol Hepatol
– volume: 143
  start-page: e621
  issue: 629–636
  year: 2012
  ident: CR2
  article-title: Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir
  publication-title: Gastroenterology
– volume: 18
  start-page: e421
  issue: 457–467
  year: 2020
  ident: 10039_CR1
  publication-title: Clin Gastroenterol Hepatol
– volume: 67
  start-page: 918
  year: 2017
  ident: 10039_CR3
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2017.07.012
– volume: 68
  start-page: 2206
  year: 2019
  ident: 10039_CR5
  publication-title: Gut
  doi: 10.1136/gutjnl-2019-318981
– volume: 63
  start-page: 1481
  year: 2016
  ident: 10039_CR9
  publication-title: Hepatology
  doi: 10.1002/hep.28438
– ident: 10039_CR10
  doi: 10.1111/hepr.12269
– volume: 18
  start-page: e717
  issue: 719–727
  year: 2020
  ident: 10039_CR12
  publication-title: Clin Gastroenterol Hepatol
– volume: 143
  start-page: e621
  issue: 629–636
  year: 2012
  ident: 10039_CR2
  publication-title: Gastroenterology
– year: 2019
  ident: 10039_CR7
  publication-title: Hepatol Int
  doi: 10.1007/s12072-019-09991-y
– volume: 68
  start-page: 425
  year: 2018
  ident: 10039_CR4
  publication-title: Hepatology
  doi: 10.1002/hep.29640
– volume: 4
  start-page: 296
  year: 2019
  ident: 10039_CR6
  publication-title: Lancet Gastroenterol Hepatol
  doi: 10.1016/S2468-1253(19)30015-9
– year: 2020
  ident: 10039_CR13
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiaa136
– volume: 9
  start-page: 43
  year: 2015
  ident: 10039_CR8
  publication-title: Hepatol Int
  doi: 10.1007/s12072-014-9593-x
– ident: 10039_CR14
– volume: 49
  start-page: 107
  year: 2019
  ident: 10039_CR11
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/apt.15058
SSID ssj0055616
Score 2.2014835
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 302
SubjectTerms Antiviral Agents - pharmacology
Antiviral drugs
Colorectal Surgery
Duration of Therapy
Editorial
Hepatitis
Hepatitis B
Hepatitis B Surface Antigens - blood
Hepatitis B virus - immunology
Hepatitis B, Chronic - drug therapy
Hepatitis B, Chronic - immunology
Hepatology
Humans
Immunity
Medicine
Medicine & Public Health
Nucleosides - pharmacology
Risk Adjustment - methods
Risk Assessment
Surgery
Withholding Treatment - ethics
Withholding Treatment - standards
Withholding Treatment - trends
Title Stopping oral antiviral treatment to cure chronic hepatitis B, is it in sight?
URI https://link.springer.com/article/10.1007/s12072-020-10039-9
https://www.ncbi.nlm.nih.gov/pubmed/32304087
https://www.proquest.com/docview/2402505767
https://www.proquest.com/docview/2391976569
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LaxsxEB6aBEoupUnaxGlqVMitEaxe-zgVt8QOKc0lMbinRbsaN4awLvH6_2dmHzYlbSGXvaykXWY00jeab0YA5yZgOS8wkkVktLTal9J76ySmBoMpA5OqmG1xE19N7fXMzbqksFXPdu9Dks1KvU1201GiJbs7ijNKZbYDe458dyZyTfWoX3_5vse4jSWTr0xopkuV-fsYf25HzzDms_hos-2M38KbDi-KUavgA3iF1SG8_tFFxI_g5rZecomFX4JT7QXJacG03QexYZCLeinK9SOKsq2DK-6RWdT1YiW-Xgh6LmqxqMSKvfQv72A6vrz7diW7OxJkaWxWy0Sht4G8qtQjYzFMXYa0ZZvI-kQ5sk7ygFIMrpgrh1zchhBSSG3wzgUXtHkPu9WywhMQISm8ylJd-qDsPLVFQbaZzNFi0JhgPADViyovuwLifI_FQ74tfczizUm8eSPePBvA502f3235jP-2Pus1kHemtMo5_MNeVJwM4NPmNRkBRzZ8hcs1tTGZIlzlYhriuNXc5nOGj72jlHpf9KrcDv7vfzl9WfMPsK95WjVUyDPYrR_X-JHgSl0MYW80-fn9cgg7k5kaNnP1CX0b37E
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9wwEB4hKkEvVaEPtoXiSnACSxvHTpwDQrQFLQX2AitxS514FlZC2YrNqur_4Ycyk8euKgoSBy65xHaieXnG880YYCv0mA8z7MqsGyqplculc9pItCH6MPcMqmK0RT_qDfTPS3O5AHdtLUyFdm9TkpWlnhe7qW6sJIc7AVeUyqSBUp7g3z8UqE32jn8QV7eVOjq8-N6TzV0CMg91Uso4QKc9RR_WIfssaE2CtLVRNO_iwJAUU6Rg0ZtsGBjkJjDkSXirvTPGG8_tDcjQvyLnw7LuDNRBa-_5fsmozl1TbE7eU1Oa8_9__nf7e-DTPsjHVtvc0Vt40_in4qAWqBVYwGIVls6aDPw76J-XY27pcCW4tF8QX0YME74RM8S6KMcin96iyOu-u-IaGbVdjibi266g56gUo0JM-FRg_z0MXoSOH2CxGBe4BsLHmQsSq3LnAz20OsvIFsRD1OgVxhh1IGhJleZNw3K-N-MmnbdaZvKmRN60Im-adGBnNud33a7jydHrLQfSRnUnKaebOGqL4g58nb0mpeNMiitwPKUxYRKQH2ciWuJjzbnZ50I-Zu9amr3bsnK--OP_8ul5wzdhuXdxdpqeHvdPPsNrxSJWwTDXYbG8neIGuUpl9qWSVAG_Xlo17gFJcxfQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9wwEB6tQEK9VEBpu4VSI9ETWGwcO49DhZbSFY-yqlRW4pY68YSuhLKIzQrxr_oTO5PHripapB645BLbiWY89oznm88Au77DLE-xJ9Oer6RWNpPWaiMx8tH5mWNQFaMthsHJSJ9dmasO_GprYSq0e5uSrGsamKWpKA9uXX6wKHxTvVBJDn08ri6VcQOrPMeHewrapp9Oj0nDH5UafLn8fCKbewVk5uu4lKGHVjuKRCKL7L9gZGKkbY4iext6hmY0RQ0ROpPmnkEmhCGvwkXaWWOccUx1QIv-subqY7Kgkeq3az_fNRnUeWyK08mTasp0_v7Pf26Fj_zbR7nZassbrMLLxlcV_XpyrUEHi3VYuWiy8a9g-L2cML3DteAyf0E6GjNk-EbM0euinIhsdociqzl4xU9kBHc5noqjfUHPcSnGhZjyCcHhBoyeRY6vYamYFPgWhAtT68WRyqzzdB7pNKV1IcxRo1MYYtAFrxVVkjXk5XyHxk2yoF1m8SYk3qQSbxJ3YW_e57am7niy9VargaQx42nCqSeO4IKwCzvz12SAnFWxBU5m1MaPPfLpTEBDvKk1N_-cz0fuvYh677eqXAz-739593_NP8DKt-NB8vV0eL4JLxTPsAqRuQVL5d0M35PXVKbb1UQV8OO5LeM3_rUcAw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Stopping+oral+antiviral+treatment+to+cure+chronic+hepatitis+B%2C+is+it+in+sight%3F&rft.jtitle=Hepatology+international&rft.au=Fan%2C+Rong&rft.au=Hou%2C+Jinlin&rft.date=2020-05-01&rft.pub=Springer+India&rft.issn=1936-0533&rft.eissn=1936-0541&rft.volume=14&rft.issue=3&rft.spage=302&rft.epage=304&rft_id=info:doi/10.1007%2Fs12072-020-10039-9&rft.externalDocID=10_1007_s12072_020_10039_9
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1936-0533&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1936-0533&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1936-0533&client=summon